• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia.

作者信息

Gkirkas Konstantinos, Stamouli Maria, Thomopoulos Thomas, Kontos Fanouris, Kavatha Dimitra, Siafakas Nikolaos, Karagiannidou Angeliki, Pournaras Spyridon, Antoniadou Anastasia, Tsirigotis Panagiotis

机构信息

Second Department of Internal Medicine, ''ATTIKON'' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Department of Microbiology, ''ATTIKON'' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Biol Blood Marrow Transplant. 2019 Sep;25(9):e298-e299. doi: 10.1016/j.bbmt.2019.07.018. Epub 2019 Jul 18.

DOI:10.1016/j.bbmt.2019.07.018
PMID:31326612
Abstract
摘要

相似文献

1
Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia.造血干细胞移植受者使用低剂量复方新诺明预防耶氏肺孢子菌肺炎对预防诺卡菌感染有效。
Biol Blood Marrow Transplant. 2019 Sep;25(9):e298-e299. doi: 10.1016/j.bbmt.2019.07.018. Epub 2019 Jul 18.
2
Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.仅接受一个月预防治疗的肾移植受者中，耶氏肺孢子菌肺炎较为罕见。
Transpl Infect Dis. 2011 Dec;13(6):570-4. doi: 10.1111/j.1399-3062.2011.00692.x. Epub 2011 Nov 17.
3
Failures of once-a-week trimethoprim-sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant.接受异基因造血干细胞移植的儿童中，每周一次的甲氧苄啶-磺胺甲恶唑预防治疗失败的情况。
Transpl Infect Dis. 2020 Feb;22(1):e13231. doi: 10.1111/tid.13231. Epub 2019 Dec 27.
4
Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.喷他脒预防接受免疫抑制化疗的儿科肿瘤患者发生肺孢子菌肺炎。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00173-18. Print 2018 Aug.
5
Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.成人异基因造血干细胞移植患者应用静脉注射喷他脒预防卡氏肺孢子菌肺炎。
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0083322. doi: 10.1128/aac.00833-22. Epub 2022 Oct 10.
6
Nocardia infection in lung transplant recipients.肺移植受者的诺卡菌感染
J Heart Lung Transplant. 2002 Mar;21(3):354-9. doi: 10.1016/s1053-2498(01)00394-1.
7
Variance in Pneumocystis jirovecii prophylaxis practice for pediatric patients undergoing hematopoietic cell transplantation.小儿造血细胞移植患者中预防卡氏肺孢子菌感染的实践存在差异。
Pediatr Blood Cancer. 2024 Oct;71(10):e31201. doi: 10.1002/pbc.31201. Epub 2024 Jul 15.
8
Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis.免疫功能低下患者在使用替代卡氏肺孢子菌预防药物时发生奴卡菌病。
Emerg Infect Dis. 2021 Oct;27(10):2734-2736. doi: 10.3201/eid2710.210620.
9
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.在现代，异基因造血细胞移植受者中肺孢子菌肺炎的发病率很高。
Cytotherapy. 2020 Jan;22(1):27-34. doi: 10.1016/j.jcyt.2019.11.002. Epub 2019 Dec 27.
10
Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.在接受异基因造血干细胞移植的患者中，阿托伐醌预防时代诺卡氏菌感染发病率的增加。
Biol Blood Marrow Transplant. 2018 Aug;24(8):1715-1720. doi: 10.1016/j.bbmt.2018.03.010. Epub 2018 Mar 16.

引用本文的文献

1
The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma.聚乙二醇化重组人粒细胞集落刺激因子在新诊断多发性骨髓瘤自体干细胞移植中的隐性成本
Sci Rep. 2025 Aug 23;15(1):30992. doi: 10.1038/s41598-025-15360-7.
2
Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients.造血干细胞移植受者中诺卡氏菌病的危险因素和结局。
Transplant Cell Ther. 2023 Mar;29(3):206.e1-206.e7. doi: 10.1016/j.jtct.2022.12.004. Epub 2022 Dec 13.
3
Invasive Nocardiosis in Transplant and Nontransplant Patients: 20-Year Experience in a Tertiary Care Center.
移植患者和非移植患者的侵袭性诺卡菌病：三级医疗中心的20年经验
Mayo Clin Proc Innov Qual Outcomes. 2021 Jan 19;5(2):298-307. doi: 10.1016/j.mayocpiqo.2020.10.009. eCollection 2021 Apr.